跳至主要内容
临床试验/CTRI/2019/05/019304
CTRI/2019/05/019304尚未招募2 期

Comparative evaluation of combined treatment using 0.03% chloroquine phosphate and 0.1% olopatadine eye drops with monotherapy using 0.1% olopatadine eye drops in patients with allergic conjunctivitis

RP Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • All patients attending the outpatient department with clinically diagnosed allergic eye disease based on signs (itching, watering) and symptoms (conjunctival hyperemia, palpebral hypertrophy) will participate in the study. No other methods of diagnosis will be considered besides clinical signs and symptoms.

排除标准

  • 1.Uveitis, conjunctivitis and other ocular pathologies
  • 2.Bronchial asthma, eczema
  • 3.History of dry eye, blepharitis, contact lens use
  • 4.Receiving topical or systemic medications
  • 5.History of sensitivity to any constituents of the eye drops

研究者

发起方
RP Centre

相似试验